XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://xconomy.com/seattle/2019/10/21/seagen-to-seek-fda-nod-after-breast-cancer-drug-hits-goals-of-key-study/60%Monthly2019-10-21 21:40
https://xconomy.com/boston/2019/10/21/backed-by-50m-verseau-launches-to-reprogram-immune-cells-against-cancer/60%Monthly2019-10-21 15:27
https://xconomy.com/boston/2019/10/18/enzyvant-adds-compasss-jeb-ledell-as-its-chief-operating-officer/60%Monthly2019-10-18 12:22
https://xconomy.com/boston/2019/10/18/pyxis-oncology-taps-medimmunes-herbst-as-chief-scientific-officer/60%Monthly2019-10-18 11:54
https://xconomy.com/national/2019/10/18/bio-roundup-ichnos-emerges-beyond-car-t-bridgebio-bails-more/60%Monthly2019-10-18 13:03
https://xconomy.com/san-francisco/2019/10/17/cytomx-taps-beigenes-amy-peterson-for-chief-development-officer/60%Monthly2019-10-17 21:21
https://xconomy.com/san-diego/2019/10/17/plexium-debuts-with-28m-and-a-new-take-on-protein-degradation-drugs/60%Monthly2019-10-17 20:57
https://xconomy.com/national/2019/10/17/healx-bags-56m-to-advance-affordable-ai-based-orphan-drugs/60%Monthly2019-10-17 13:07
https://xconomy.com/boston/2019/10/17/nuance-microsoft-team-up-on-conversational-ai-for-doctors-offices/60%Monthly2019-10-16 20:49
https://xconomy.com/san-francisco/2019/10/17/arsenalbio-launches-with-85m-for-programmable-t-cell-therapies/60%Monthly2019-10-17 12:46
https://xconomy.com/indiana/2019/10/16/eli-lilly-drug-acquired-in-armo-deal-fails-pancreatic-cancer-test/60%Monthly2019-10-16 16:50
https://xconomy.com/boston/2019/10/16/alexion-to-buy-achillion-in-930m-marriage-of-rare-disease-drug-firms/60%Monthly2019-10-16 13:51
https://xconomy.com/boston/2019/10/15/checkmate-pharmaceuticals-names-wooldridge-chief-medical-officer/60%Monthly2019-10-15 19:22
https://xconomy.com/san-francisco/2019/10/15/second-genomes-mcclure-joins-aligos-as-chief-medical-officer/60%Monthly2019-10-15 19:14
https://xconomy.com/new-york/2019/10/15/led-by-gilead-veteran-riva-glenmarks-ichnos-steps-out-on-its-own/60%Monthly2019-10-16 13:42
https://xconomy.com/boston/2019/10/15/cyteir-adds-40m-for-clinical-test-of-synthetically-lethal-cancer-drug/60%Monthly2019-10-15 12:21
https://xconomy.com/san-francisco/2019/10/14/revance-ceo-browne-resigns-board-member-foley-appointed-successor/60%Monthly2019-10-15 16:40
https://xconomy.com/boston/2019/10/14/parexels-washburn-named-lyra-therapeutics-chief-medical-officer/60%Monthly2019-10-14 14:15
https://xconomy.com/indiana/2019/10/11/fda-oks-lillys-lasmiditan-first-new-acute-migraine-drug-in-decades/60%Monthly2019-10-14 13:08
https://xconomy.com/san-francisco/2019/10/11/xconomy-presents-whats-next-in-neuroscience-therapies/60%Monthly2019-10-11 15:08
https://xconomy.com/san-diego/2019/10/11/poseida-therapeutics-brings-in-amgens-kerry-ingalls-as-coo/60%Monthly2019-10-11 14:50
https://xconomy.com/san-francisco/2019/10/11/vir-bios-ipo-brings-in-143m-for-tests-of-hepatitis-b-drug-and-more/60%Monthly2019-10-11 13:47
https://xconomy.com/national/2019/10/11/bio-roundup-nobel-prizes-placebo-effect-rises-icers-fire-more/60%Monthly2019-10-11 10:40
https://xconomy.com/boston/2019/10/10/ucb-stakes-out-autoimmune-territory-with-2-1b-deal-for-ra-pharma/60%Monthly2019-10-11 16:55
https://xconomy.com/national/2019/10/10/the-placebo-effect-is-hobbling-new-psychiatric-drugs-what-can-stop-it/60%Monthly2019-10-10 18:29
https://xconomy.com/san-francisco/2019/10/09/jazz-pharmas-matthew-young-to-join-grail-as-coo-cfo/60%Monthly2019-10-09 16:04
https://xconomy.com/boston/2019/10/09/cue-biopharma-promotes-suri-to-president-passeri-keeps-ceo-role/60%Monthly2019-10-09 15:50
https://xconomy.com/wisconsin/2019/10/09/wi-watchlist-epic-venture-investors-stratatech-rockwell-more/60%Monthly2019-10-08 21:21
https://xconomy.com/san-francisco/2019/10/09/five-years-after-y-combinator-first-admits-biotechs-theyre-dug-in/60%Monthly2019-10-08 23:19
https://xconomy.com/national/2019/10/09/pharma-biotech-vc-investments-continue-shift-to-early-stage-deals/60%Monthly2019-10-09 04:42
https://xconomy.com/san-francisco/2019/10/08/biomarin-promotes-lon-cardon-to-chief-scientific-strategy-officer/60%Monthly2019-10-09 16:18
https://xconomy.com/san-francisco/2019/10/08/tempest-therapeutics-taps-stephen-brady-for-chief-operating-officer/60%Monthly2019-10-08 20:26
https://xconomy.com/san-francisco/2019/10/08/genentechs-merdad-parsey-to-join-gilead-as-chief-medical-officer/60%Monthly2019-10-08 20:08
https://xconomy.com/boston/2019/10/08/verve-therapeutics-names-lyndras-bellinger-chief-scientific-officer/60%Monthly2019-10-08 15:49
https://xconomy.com/san-diego/2019/10/08/labfellows-looks-to-become-operating-system-for-life-sciences-cos/60%Monthly2019-10-12 02:21
https://xconomy.com/boston/2019/10/08/catch-duchenne-patient-power-phil-sharp-more-next-week-at-the-broad/60%Monthly2019-10-07 13:59
https://xconomy.com/boston/2019/10/08/with-65m-cygnal-tunes-in-to-nerve-signals-for-drug-making-clues/60%Monthly2019-10-08 13:09
https://xconomy.com/national/2019/10/07/nobel-prize-in-medicine-goes-to-3-who-showed-how-cells-sense-oxygen-levels/60%Monthly2019-10-07 21:41
https://xconomy.com/boston/2019/10/07/akcea-fresh-off-c-suite-shakeup-dishes-heart-drug-to-pfizer-for-250m/60%Monthly2019-10-07 12:42
https://xconomy.com/san-diego/2019/10/07/precision-ibd-rebrands-as-prometheus-and-strikes-rd-deal-with-takeda/60%Monthly2019-10-05 00:33
https://xconomy.com/boston/2019/10/07/unpack-digital-healths-progress-pitfalls-at-x%c2%b7con-on-oct-22/60%Monthly2019-10-04 15:26
https://xconomy.com/wisconsin/2019/10/04/fetch-rewards-grabs-25m-plans-to-double-staff-as-growth-accelerates/60%Monthly2019-10-04 19:13
https://xconomy.com/national/2019/10/04/bio-roundup-parp-progress-a-new-commish-ipo-palooza-more/60%Monthly2019-10-04 10:48
https://xconomy.com/san-diego/2019/10/03/after-brain-cancer-drug-fails-tocagen-to-cut-more-than-half-of-staff/60%Monthly2019-10-04 00:31
https://xconomy.com/boston/2019/10/03/vertex-pharma-promotes-bozic-as-kewalramanis-successor/60%Monthly2019-10-03 20:15
https://xconomy.com/san-francisco/2019/10/03/nektar-promotes-zalevsky-to-chief-rd-officer-labrucherie-to-coo/60%Monthly2019-10-03 20:07
https://xconomy.com/national/2019/10/03/three-biotechs-raise-320m-in-ipos-two-others-pass-on-wall-street/60%Monthly2019-10-03 16:01
https://xconomy.com/seattle/2019/10/03/icosavax-lands-51m-to-bring-vaccine-for-respiratory-virus-to-clinic/60%Monthly2019-10-03 03:27
https://xconomy.com/san-francisco/2019/10/02/nuance-spinout-cerence-vies-with-tech-giants-in-voice-ai-for-auto/60%Monthly2019-10-02 22:24
https://xconomy.com/san-diego/2019/10/02/viscient-bio-proposes-organovo-merger-to-tackle-nash-and-go-beyond/60%Monthly2019-10-04 17:49
https://xconomy.com/san-diego/2019/10/01/avidity-biosciences-taps-former-akcea-exec-sarah-boyce-as-new-ceo/60%Monthly2019-10-02 00:44
https://xconomy.com/national/2019/10/01/bayer-and-arvinas-appoint-john-dombrosky-ceo-of-joint-venture-oerth/60%Monthly2019-10-03 20:40
https://xconomy.com/boston/2019/10/01/dyne-appoints-brumm-president-ceo-subramanian-shifts-to-cso/60%Monthly2019-10-03 16:12
https://xconomy.com/san-francisco/2019/10/01/sangamo-taps-cytokinetics-exec-cockroft-for-chief-medical-officer/60%Monthly2019-10-02 19:21
https://xconomy.com/texas/2019/10/01/can-fords-self-driving-car-business-improve-austins-traffic-woes/60%Monthly2019-10-01 19:55
https://xconomy.com/san-diego/2019/10/01/molecular-assemblies-raises-12m-to-advance-enzymatic-dna-synthesis/60%Monthly2019-10-01 14:26
https://xconomy.com/new-york/2019/10/01/biogens-ehlers-leaving-for-apple-tree-steps-into-limelight-as-ceo/60%Monthly2019-10-01 16:37
https://xconomy.com/boston/2019/10/01/were-beginning-to-realize-the-clouds-full-potential-at-the-edge/60%Monthly2019-10-01 13:15
https://xconomy.com/national/2019/10/01/esmo-2019-parp-and-prostate-seagens-win-kras-update-more/60%Monthly2019-10-01 10:32